ZLN024 hydrochloride is primarily utilized in research settings, particularly in the study of neurological disorders. It functions as a selective agonist for the GPR17 receptor, which plays a significant role in regulating oligodendrocyte differentiation and myelination processes. This makes it a valuable tool for investigating conditions like multiple sclerosis, where myelination is impaired. Researchers use ZLN024 hydrochloride to explore potential therapeutic strategies aimed at promoting remyelination and improving neuronal function. Its application extends to in vitro and in vivo studies, helping to unravel the molecular mechanisms underlying GPR17 receptor activity and its implications in central nervous system repair and regeneration.